{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["BBI", "COVID-19", "SARS-CoV-2", "anti-viral", "isoquinoline and related alkaloid"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36671402", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "24"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "21"}], "Language": ["eng"], "ELocationID": ["17", "10.3390/biom13010017"], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "13", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "21"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight.", "Abstract": {"AbstractText": ["Viruses are widely recognized as the primary cause of infectious diseases around the world. The ongoing global pandemic due to the emergence of SARS-CoV-2 further added fuel to the fire. The development of therapeutics becomes very difficult as viruses can mutate their genome to become more complex and resistant. Medicinal plants and phytocompounds could be alternative options. Isoquinoline and their related alkaloids are naturally occurring compounds that interfere with multiple pathways including nuclear factor-\u03baB, mitogen-activated protein kinase/extracellular-signal-regulated kinase, and inhibition of Ca<sup>2+</sup>-mediated fusion. These pathways play a crucial role in viral replication. Thus, the major goal of this study is to comprehend the function of various isoquinoline and related alkaloids in viral infections by examining their potential mechanisms of action, structure-activity relationships (SAR), in silico (particularly for SARS-CoV-2), in vitro and in vivo studies. The current advancements in isoquinoline and related alkaloids as discussed in the present review could facilitate an in-depth understanding of their role in the drug discovery process."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, Sector-III, Pushp Vihar, New Delhi 110017, India."}], "LastName": "Sharma", "ForeName": "Divya", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Delhi Institute of Pharmaceutical Sciences and Research, Delhi Pharmaceutical Sciences and Research University, Sector-III, Pushp Vihar, New Delhi 110017, India."}], "LastName": "Sharma", "ForeName": "Neetika", "Initials": "N"}, {"Identifier": ["0000-0003-0152-5207"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, Sector-III, Pushp Vihar, New Delhi 110017, India."}], "LastName": "Manchanda", "ForeName": "Namish", "Initials": "N"}, {"Identifier": ["0000-0002-4762-9733"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur 440033, India."}], "LastName": "Prasad", "ForeName": "Satyendra K", "Initials": "SK"}, {"Identifier": ["0000-0003-1920-3855"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, Sector-III, Pushp Vihar, New Delhi 110017, India."}], "LastName": "Sharma", "ForeName": "Prabodh Chander", "Initials": "PC"}, {"Identifier": ["0000-0002-0790-2264"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biorefining and Advanced Materials Research Centre, Scotland's Rural College (SRUC), Kings Buildings, 11 West Mains Road, Edinburgh EH9 3JG, UK."}, {"Identifier": [], "Affiliation": "School of Engineering, University of Petroleum & Energy Studies (UPES), Dehradun 248007, India."}], "LastName": "Thakur", "ForeName": "Vijay Kumar", "Initials": "VK"}, {"Identifier": ["0000-0001-8180-7970"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical and Natural Products Chemistry, School of Health, Sports and Bioscience, University of East London, Stratford Campus, London E15 4LZ, UK."}], "LastName": "Rahman", "ForeName": "M Mukhlesur", "Initials": "MM"}, {"Identifier": ["0000-0002-9148-5714"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, Sector-III, Pushp Vihar, New Delhi 110017, India."}], "LastName": "Dhobi", "ForeName": "Mahaveer", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoquinolines"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Viruses"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Isoquinolines"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Caldaria A., Conforti C., Di Meo N., Dianzani C., Jafferany M., Lotti T., Zalaudek I., Giuffrida R. COVID-19 and SARS: Differences and similarities. Dermatol. Ther. 2020;33:e13395. doi: 10.1111/dth.13395.", "ArticleIdList": ["10.1111/dth.13395", "PMC7235519", "32277530"]}, {"Citation": "Rabaan A.A., Al-Ahmed S.H., Haque S., Sah R., Tiwari R., Malik Y.S., Dhama K., Yatoo M.I., Bonilla-Aldana D.K., Rodriguez-Morales A.J. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez Med. 2020;28:174\u2013184.", "ArticleIdList": ["32275259"]}, {"Citation": "Chen Z., Boon S.S., Wang M.H., Chan R.W.Y., Chan P.K.S. Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses. J. Virol. Methods. 2021;289:114032. doi: 10.1016/j.jviromet.2020.114032.", "ArticleIdList": ["10.1016/j.jviromet.2020.114032", "PMC7718587", "33290786"]}, {"Citation": " [(accessed on 9 November 2022)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/hiv-aids#:~:text=HIV%20continues%20to%20be%20a,no%20cure%20for%20HIV%20infection."}, {"Citation": " [(accessed on 24 June 2022)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=HBV%2DHIV%20coinfection&text=Conversely%2C%20the%20global%20prevalence%20of,%2Dinfected%20persons%20is%207.4%25."}, {"Citation": "Ball M.J., Lukiw W.J., Kammerman E.M., Hill J.M. Intracerebral propagation of Alzheimer\u2019s disease: Strengthening evidence of a herpes simplex virus etiology. Alzheimer\u2019s Dement. 2013;9:169\u2013175. doi: 10.1016/j.jalz.2012.07.005.", "ArticleIdList": ["10.1016/j.jalz.2012.07.005", "PMC3578985", "23159044"]}, {"Citation": "Hober D., Sane F., Jaidane H., Riedweg K., Goffard A., Desailloud R. Immunology in the clinic review series; focus on type 1 diabetes and viruses: Role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes. Clin. Exp. Immunol. 2012;168:47\u201351. doi: 10.1111/j.1365-2249.2011.04559.x.", "ArticleIdList": ["10.1111/j.1365-2249.2011.04559.x", "PMC3390492", "22385236"]}, {"Citation": "Morgan R.L., Baack B., Smith B.D., Yartel A., Pitasi M., Falck-Ytter Y. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: A meta-analysis of observational studies. Pt 1Ann. Intern. Med. 2013;158:329\u2013337. doi: 10.7326/0003-4819-158-5-201303050-00005.", "ArticleIdList": ["10.7326/0003-4819-158-5-201303050-00005", "23460056"]}, {"Citation": "Kharb R., Shahar Yar M., Sharma P.C. Recent advances and future perspectives of triazole analogs as promising antiviral agents. Mini Rev. Med. Chem. 2011;11:84\u201396. doi: 10.2174/138955711793564051.", "ArticleIdList": ["10.2174/138955711793564051", "21034403"]}, {"Citation": "Parra A.L., Bezerra L.P., Shawar D.E., Neto N.A., Mesquita F.P., Silva G.O.D., Souza P.F. Synthetic antiviral peptides: A new way to develop targeted antiviral drugs. Future Virol. 2022;17:577\u2013591. doi: 10.2217/fvl-2021-0308.", "ArticleIdList": ["10.2217/fvl-2021-0308"]}, {"Citation": "Serban G. Synthetic Compounds with 2-Amino-1,3,4-Thiadiazole Moiety Against Viral Infections. Molecules. 2020;25:942. doi: 10.3390/molecules25040942.", "ArticleIdList": ["10.3390/molecules25040942", "PMC7070519", "32093125"]}, {"Citation": "Wang Y., Ling L., Zhang Z., Marin-Lopez A. Current Advances in Zika Vaccine Development. Vaccines. 2022;10:1816. doi: 10.3390/vaccines10111816.", "ArticleIdList": ["10.3390/vaccines10111816", "PMC9694033", "36366325"]}, {"Citation": "Burki T. The origin of SARS-CoV-2 variants of concern. Lancet Infect. Dis. 2022;22:174\u2013175. doi: 10.1016/S1473-3099(22)00015-9.", "ArticleIdList": ["10.1016/S1473-3099(22)00015-9", "PMC9760347", "35033232"]}, {"Citation": "Nov\u00e1kov\u00e1 L., Pavl\u00edk J., Chrenkov\u00e1 L., Martinec O., \u010cerven\u00fd L. Current antiviral drugs and their analysis in biological materials\u2013Part II: Antivirals against hepatitis and HIV viruses. J. Pharm. Biomed. Anal. 2018;147:378\u2013399. doi: 10.1016/j.jpba.2017.07.003.", "ArticleIdList": ["10.1016/j.jpba.2017.07.003", "29031512"]}, {"Citation": "Ganjhu R.K., Mudgal P.P., Maity H., Dowarha D., Devadiga S., Nag S., Arunkumar G. Herbal plants and plant preparations as remedial approach for viral diseases. Virus Dis. 2015;26:225\u2013236. doi: 10.1007/s13337-015-0276-6.", "ArticleIdList": ["10.1007/s13337-015-0276-6", "PMC4663710", "26645032"]}, {"Citation": "Kitazato K., Wang Y., Kobayashi N. Viral infectious disease and natural products with antiviral activity. Drug Discov. 2007;1:14\u201322.", "ArticleIdList": ["22504360"]}, {"Citation": "Adhikari B., Marasini B.P., Rayamajhee B., Bhattarai B.R., Lamichhane G., Khadayat K., Adhikari A., Khanal S., Parajuli N. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review. Phytother. Res. 2021;35:1298\u20131312. doi: 10.1002/ptr.6893.", "ArticleIdList": ["10.1002/ptr.6893", "PMC7675695", "33037698"]}, {"Citation": "Wang K., Conlon M., Ren W., Chen B.B., B\u0105czek T. Natural Products as Targeted Modulators of the Immune System. J. Immunol. Res. 2018;2018:7862782. doi: 10.1155/2018/7862782.", "ArticleIdList": ["10.1155/2018/7862782", "PMC6369473", "30809554"]}, {"Citation": "Khanna K., Kohli S.K., Kaur R., Bhardwaj A., Bhardwaj V., Ohri P., Sharma A., Ahmad A., Bhardwaj R., Ahmad P. Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle. Phytomed. Int. J. Phytother. Phytopharm. 2021;85:153361. doi: 10.1016/j.phymed.2020.153361.", "ArticleIdList": ["10.1016/j.phymed.2020.153361", "PMC7532351", "33485605"]}, {"Citation": "Sharma P.C., Sharma O., Vasudeva N., Mishra D., Singh S. Anti-HIV substances of natural origin\u2013An updated account. Nat. Prod. Radiance. 2006:70\u201378."}, {"Citation": "Patel B., Sharma S., Nair N., Majeed J., Goyal R.K., Dhobi M. Therapeutic opportunities of edible antiviral plants for COVID-19. Mol Cell Biochem. 2021;476:2345\u20132364. doi: 10.1007/s11010-021-04084-7.", "ArticleIdList": ["10.1007/s11010-021-04084-7", "PMC7882868", "33587232"]}, {"Citation": "Mrityunjaya M., Pavithra V., Neelam R., Janhavi P., Halami P., Ravindra P. Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19. Front. Immunol. 2020:2337. doi: 10.3389/fimmu.2020.570122.", "ArticleIdList": ["10.3389/fimmu.2020.570122", "PMC7575721", "33117359"]}, {"Citation": "Zhang D.-H., Wu K.-L., Zhang X., Deng S.-Q., Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J. Integr. Med. 2020;18:152\u2013158. doi: 10.1016/j.joim.2020.02.005.", "ArticleIdList": ["10.1016/j.joim.2020.02.005", "PMC7102521", "32113846"]}, {"Citation": "Omrani M., Keshavarz M., Nejad Ebrahimi S., Mehrabi M., Mcgaw L.J., Ali Abdalla M., Mehrbod P. Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines. Front. Pharmacol. 2021;11 doi: 10.3389/fphar.2020.586993.", "ArticleIdList": ["10.3389/fphar.2020.586993", "PMC7926205", "33679384"]}, {"Citation": "Erika P., Avila M M.C., Mu\u00f1oz D.R., Cuca S L.E. Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases. Pharmacol. Res. 2022;177:106126. doi: 10.1016/j.phrs.2022.106126.", "ArticleIdList": ["10.1016/j.phrs.2022.106126", "35151857"]}, {"Citation": "Qing Z.-X., Yang P., Tang Q., Cheng P., Liu X.-B., Zheng Y.-J., Liu Y.-S., Zeng J.-G. Isoquinoline Alkaloids and Their Antiviral, Antibacterial, and Antifungal Activities and Structure-activity Relationship. Curr. Org. Chem. 2017;21:1920\u20131934. doi: 10.2174/1385272821666170207114214.", "ArticleIdList": ["10.2174/1385272821666170207114214"]}, {"Citation": "Warowicka A., Nawrot R., Go\u017adzicka-J\u00f3zefiak A. Antiviral activity of berberine. Arch. Virol. 2020;165:1935\u20131945. doi: 10.1007/s00705-020-04706-3.", "ArticleIdList": ["10.1007/s00705-020-04706-3", "PMC7320912", "32594322"]}, {"Citation": "Souto A.L., Tavares J.F., Da Silva M.S., Diniz M.D.F.F.M., De Athayde-Filho P.F., Barbosa Filho J.M. Anti-inflammatory activity of alkaloids: An update from 2000 to 2010. Molecules. 2011;16:8515\u20138534. doi: 10.3390/molecules16108515.", "ArticleIdList": ["10.3390/molecules16108515", "PMC6264344", "21989312"]}, {"Citation": "Bribi N. Pharmacological activity of Alkaloids: A Review. Asian J. Bot. 2018:1\u20136. doi: 10.63019/ajb.v1i2.467.", "ArticleIdList": ["10.63019/ajb.v1i2.467"]}, {"Citation": "Yan Y., Li X., Zhang C., Lv L., Gao B., Li M. Research Progress on Antibacterial Activities and Mechanisms of Natural Alkaloids: A Review. Antibiotics. 2021;10:318. doi: 10.3390/antibiotics10030318.", "ArticleIdList": ["10.3390/antibiotics10030318", "PMC8003525", "33808601"]}, {"Citation": "Mondal A., Gandhi A., Fimognari C., Atanasov A.G., Bishayee A. Alkaloids for cancer prevention and therapy: Current progress and future perspectives. Eur. J. Pharm. 2019;858:172472. doi: 10.1016/j.ejphar.2019.172472.", "ArticleIdList": ["10.1016/j.ejphar.2019.172472", "31228447"]}, {"Citation": "Khan H., Mubarak M.S., Amin S. Antifungal Potential of Alkaloids As An Emerging Therapeutic Target. Curr Drug Targets. 2017;18:1825\u20131835. doi: 10.2174/1389450117666160719095517.", "ArticleIdList": ["10.2174/1389450117666160719095517", "27440186"]}, {"Citation": "Farnsworth N.R., Svoboda G.H., Blomster R.N. Antiviral Activity of Selected Catharanthus Alkaloids. J. Pharm. Sci. 1968;57:2174\u20132175. doi: 10.1002/jps.2600571235.", "ArticleIdList": ["10.1002/jps.2600571235", "4303510"]}, {"Citation": "Renard-Nozaki J., Kim T., Imakura Y., Kihara M., Kobayashi S. Effect of alkaloids isolated from Amaryllidaceae on herpes simplex virus. Res. Virol. 1989;140:115\u2013128. doi: 10.1016/S0923-2516(89)80089-5.", "ArticleIdList": ["10.1016/S0923-2516(89)80089-5", "2547235"]}, {"Citation": "Topcu G.S.H., Toraman G.O.A., Altan V.M. Natural alkaloids as potential anti-coronavirus compounds. (Special Issue: Therapeutic options and potential vaccine studies against COVID-19. Bezmialem Sci. 2020;8:131\u2013139. doi: 10.14235/bas.galenos.2020.5035.", "ArticleIdList": ["10.14235/bas.galenos.2020.5035"]}, {"Citation": "Ramawat K.G. In: Biodiversity and Chemotaxonomy. Ramawat K.G., editor. Vol. 24 Springer; Berlin/Heidelberg, Germany: 2019. Sustainable Development and Biodiversity."}, {"Citation": "Santoro D., Bellinghieri G., Savica V. Development of the concept of pain in history. J. Nephrol. 2011;24((Suppl. 17)):S133\u2013S136. doi: 10.5301/JN.2011.6481.", "ArticleIdList": ["10.5301/JN.2011.6481", "21614795"]}, {"Citation": "Kukula-Koch W.A., Widelski J. In: Chapter 9\u2014Alkaloids, Pharmacognosy. Badal S., Delgoda R., editors. Academic Press; Boston, MA, USA: 2017. pp. 163\u2013198."}, {"Citation": "Qing Z., Xu Y., Yu L., Liu J., Huang X., Tang Z., Cheng P., Zeng J. Investigation of fragmentation behaviours of isoquinoline alkaloids by mass spectrometry combined with computational chemistry. Sci. Rep. 2020;10:733. doi: 10.1038/s41598-019-57406-7.", "ArticleIdList": ["10.1038/s41598-019-57406-7", "PMC6970995", "31959815"]}, {"Citation": "Qing Z.-X., Huang J.-L., Yang X.-Y., Liu J.-H., Cao H.-L., Xiang F., Cheng P., Zeng J.-G. Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship. Curr. Med. Chem. 2018;25:5088\u20135114. doi: 10.2174/0929867324666170920125135.", "ArticleIdList": ["10.2174/0929867324666170920125135", "28933285"]}, {"Citation": "Shang X.-F., Yang C.-J., Morris-Natschke S.L., Li J.-C., Yin X.-D., Liu Y.-Q., Guo X., Peng J.-W., Goto M., Zhang J.-Y., et al. Biologically active isoquinoline alkaloids covering 2014\u20132018. Med. Res. Rev. 2020;40:2212\u20132289. doi: 10.1002/med.21703.", "ArticleIdList": ["10.1002/med.21703", "PMC7554109", "32729169"]}, {"Citation": "Fielding B.C., Da Silva Maia Bezerra Filho C., Ismail N.S.M., Sousa D.P.D. Alkaloids: Therapeutic Potential against Human Coronaviruses. Molecules. 2020;25:5496. doi: 10.3390/molecules25235496.", "ArticleIdList": ["10.3390/molecules25235496", "PMC7727683", "33255253"]}, {"Citation": "Majnooni M.B., Fakhri S., Bahrami G., Naseri M., Farzaei M.H., Echeverr\u00eda J. Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms. Evid. -Based Complement. Altern. Med. 2021;2021:6632623. doi: 10.1155/2021/6632623.", "ArticleIdList": ["10.1155/2021/6632623", "PMC8159655", "34104202"]}, {"Citation": "Abookleesh F.L., Al-Anzi B.S., Ullah A. Potential Antiviral Action of Alkaloids. Molecules. 2022;27:903. doi: 10.3390/molecules27030903.", "ArticleIdList": ["10.3390/molecules27030903", "PMC8839337", "35164173"]}, {"Citation": "Goyal R.K., Majeed J., Tonk R., Dhobi M., Patel B., Sharma K., Apparsundaram S. Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection. Rev. Cardiovasc. Med. 2020;21:365\u2013384. doi: 10.31083/j.rcm.2020.03.118.", "ArticleIdList": ["10.31083/j.rcm.2020.03.118", "33070542"]}, {"Citation": "Maurya V.K., Kumar S., Prasad A.K., Bhatt M.L., Saxena S.K. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virusdisease. 2020;31:179\u2013193. doi: 10.1007/s13337-020-00598-8.", "ArticleIdList": ["10.1007/s13337-020-00598-8", "PMC7245990", "32656311"]}, {"Citation": "Chowdhury P. In silico investigation of phytoconstituents from Indian medicinal herb \u2018Tinospora cordifolia (giloy)\u2019against SARS-CoV-2 (COVID-19) by molecular dynamics approach. J. Biomol. Struct. Dyn. 2021;39:6792\u20136809. doi: 10.1080/07391102.2020.1803968.", "ArticleIdList": ["10.1080/07391102.2020.1803968", "PMC7484574", "32762511"]}, {"Citation": "Joshi T., Bhat S., Pundir H., Chandra S. Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study. J. Mol. Graph. Model. 2021;109:108028. doi: 10.1016/j.jmgm.2021.108028.", "ArticleIdList": ["10.1016/j.jmgm.2021.108028", "PMC8504924", "34649146"]}, {"Citation": "Kumar N., Sood D., Van Der Spek P.J., Sharma H.S., Chandra R. Molecular binding mechanism and pharmacology comparative analysis of noscapine for repurposing against SARS-CoV-2 protease. J. Proteome Res. 2020;19:4678\u20134689. doi: 10.1021/acs.jproteome.0c00367.", "ArticleIdList": ["10.1021/acs.jproteome.0c00367", "32786685"]}, {"Citation": "Jadhav V., Ingle S., Ahmed R. Inhibitory activity of palmatine on main protease complex (mpro) of SARS-CoV-2. Rom. J. Biophys. 2021;31:27\u201340. doi: 10.21203/rs.3.rs-38145/v1.", "ArticleIdList": ["10.21203/rs.3.rs-38145/v1"]}, {"Citation": "Yan J., Shen X., Cao Y., Zhang J., Wang Y., Cheng Y. Discovery of Anti-2019-nCoV Agents from 38 Chinese Patent Drugs toward Respiratory Diseases via Docking Screening. Preprints. 2020 doi: 10.20944/preprints202002.0254.v2.", "ArticleIdList": ["10.20944/preprints202002.0254.v2"]}, {"Citation": "Jain D., Hossain R., Khan R., Dey D., Toma T.R., Islam M., Pracheta D., Khalid R., Hakeem K. Computer-aided Evaluation of Anti-SARS-CoV-2 (3-chymotrypsin-like Protease and Transmembrane Protease Serine 2 Inhibitors) Activity of Cepharanthine: An In silico Approach. Biointerface Res. Appl. Chem. 2021;12:768\u2013780."}, {"Citation": "Byler K.G., Ogungbe I.V., Setzer W.N. Setzer In-silico screening for anti-Zika virus phytochemicals. J. Mol. Graph. Model. 2016;69:78\u201391. doi: 10.1016/j.jmgm.2016.08.011.", "ArticleIdList": ["10.1016/j.jmgm.2016.08.011", "PMC7185537", "27588363"]}, {"Citation": "Sadeghi M., Miroliaei M. Inhibitory effects of selected isoquinoline alkaloids against main protease (Mpro) of SARS-CoV-2, in silico study. Silico Pharmacol. 2022;10:1\u20138. doi: 10.1007/s40203-022-00122-4.", "ArticleIdList": ["10.1007/s40203-022-00122-4", "PMC8918422", "35310017"]}, {"Citation": "Garg S., Roy A. In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2. Chem.-Biol. Interact. 2020;332:109309. doi: 10.1016/j.cbi.2020.109309.", "ArticleIdList": ["10.1016/j.cbi.2020.109309", "PMC7649659", "33181114"]}, {"Citation": "Rogosnitzky M., Okediji P., Koman I. Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19. Pharmacol. Rep. 2020;72:1509\u20131516. doi: 10.1007/s43440-020-00132-z.", "ArticleIdList": ["10.1007/s43440-020-00132-z", "PMC7375448", "32700247"]}, {"Citation": "Hijikata A., Shionyu-Mitsuyama C., Nakae S., Shionyu M., Ota M., Kanaya S., Hirokawa T., Nakajima S., Watashi K., Shirai T. Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2. FEBS Open Bio. 2022;12:285\u2013294. doi: 10.1002/2211-5463.13337.", "ArticleIdList": ["10.1002/2211-5463.13337", "PMC8727928", "34850606"]}, {"Citation": "Kumar D., Kumari K., Jayaraj A., Kumar V., Kumar R.V., Dass S.K., Chandra R., Singh P. Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures. J. Biomol. Struct. Dyn. 2021;39:2659\u20132672. doi: 10.1080/07391102.2020.1752310.", "ArticleIdList": ["10.1080/07391102.2020.1752310", "PMC7212547", "32362235"]}, {"Citation": "Agrawal A., Jain N.K., Kumar N., Kulkarni G.T. Molecular docking study to identify a potential inhibitor of covid-19 main protease enzyme: An in-silico approach. ChemRxiv. 2020 doi: 10.26434/chemrxiv.12170904.v1. Cambridge: Cambridge Open Engage; This content is a preprint and has not been peer-reviewed.", "ArticleIdList": ["10.26434/chemrxiv.12170904.v1"]}, {"Citation": "Song S., Qiu M., Chu Y., Chen D., Wang X., Su A., Wu Z. Downregulation of cellular c-Jun N-terminal protein kinase and NF-\u03baB activation by berberine may result in inhibition of herpes simplex virus replication. Antimicrob. Agents Chemother. 2014;58:5068\u20135078. doi: 10.1128/AAC.02427-14.", "ArticleIdList": ["10.1128/AAC.02427-14", "PMC4135844", "24913175"]}, {"Citation": "Zha W., Liang G., Xiao J., Studer E.J., Hylemon P.B., Pandak W.M., Jr., Wang G., Li X., Zhou H. Berberine Inhibits HIV Protease Inhibitor-Induced Inflammatory Response by Modulating ER Stress Signaling Pathways in Murine Macrophages. PLoS ONE. 2010;5:e9069. doi: 10.1371/journal.pone.0009069.", "ArticleIdList": ["10.1371/journal.pone.0009069", "PMC2817721", "20161729"]}, {"Citation": "Wang Z.Z., Li K., Maskey A.R., Huang W., Toutov A.A., Yang N., Srivastava K., Geliebter J., Tiwari R., Miao M. A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study. FASEB J. 2021;35:e21360. doi: 10.1096/fj.202001792R.", "ArticleIdList": ["10.1096/fj.202001792R", "PMC8250068", "33749932"]}, {"Citation": "Pizzorno A., Padey B., Dubois J., Julien T., Traversier A., Duli\u00e8re V., Brun P., Lina B., Rosa-Calatrava M., Terrier O. In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Antivir. Res. 2020;181:104878. doi: 10.1016/j.antiviral.2020.104878.", "ArticleIdList": ["10.1016/j.antiviral.2020.104878", "PMC7361110", "32679055"]}, {"Citation": "Ghareeb D.A., Saleh S.R., Seadawy M.G., Nofal M.S., Abdulmalek S.A., Hassan S.F., Khedr S.M., Abdelwahab M.G., Sobhy A.A., Yassin A.M. Nanoparticles of ZnO/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity. J. Pharm. Investig. 2021;51:735\u2013757. doi: 10.1007/s40005-021-00544-w.", "ArticleIdList": ["10.1007/s40005-021-00544-w", "PMC8419391", "34513113"]}, {"Citation": "Varghese F.S., Van Woudenbergh E., Overheul G.J., Eleveld M.J., Kurver L., Van Heerbeek N., Van Laarhoven A., Miesen P., Den Hartog G., De Jonge M.I. Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial cells in vitro. Viruses. 2021;13:282. doi: 10.3390/v13020282.", "ArticleIdList": ["10.3390/v13020282", "PMC7918080", "33670363"]}, {"Citation": "Cecil C.E., Davis J.M., Cech N.B., Laster S.M. Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid berberine and extracts of goldenseal (Hydrastis canadensis) Int. Immunopharmacol. 2011;11:1706\u20131714. doi: 10.1016/j.intimp.2011.06.002.", "ArticleIdList": ["10.1016/j.intimp.2011.06.002", "21683808"]}, {"Citation": "Varghese F.S., Thaa B., Amrun S.N., Simarmata D., Rausalu K., Nyman T.A., Merits A., Mcinerney G.M., Ng L.F.P., Ahola T. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling. J. Virol. 2016;90:9743\u20139757. doi: 10.1128/JVI.01382-16.", "ArticleIdList": ["10.1128/JVI.01382-16", "PMC5068526", "27535052"]}, {"Citation": "Botwina P., Owczarek K., Rajfur Z., Ochman M., Urlik M., Nowakowska M., Szczubia\u0142ka K., Pyrc K. Berberine hampers influenza a replication through inhibition of MAPK/ERK pathway. Viruses. 2020;12:344. doi: 10.3390/v12030344.", "ArticleIdList": ["10.3390/v12030344", "PMC7150991", "32245183"]}, {"Citation": "Yan Y.Q., Fu Y.J., Wu S., Qin H.Q., Zhen X., Song B.M., Weng Y.S., Wang P.C., Chen X.Y., Jiang Z.Y. Anti-influenza activity of berberine improves prognosis by reducing viral replication in mice. Phytother. Res. 2018;32:2560\u20132567. doi: 10.1002/ptr.6196.", "ArticleIdList": ["10.1002/ptr.6196", "30306659"]}, {"Citation": "Luganini A., Mercorelli B., Messa L., Pal\u00f9 G., Gribaudo G., Loregian A. The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity. Antivir. Res. 2019;164:52\u201360. doi: 10.1016/j.antiviral.2019.02.006.", "ArticleIdList": ["10.1016/j.antiviral.2019.02.006", "30738836"]}, {"Citation": "Wu Y.R., Ma Y.B., Zhao Y.X., Yao S.Y., Zhou J., Zhou Y., Chen J.J. Two new quaternary alkaloids and anti-hepatitis B virus active constituents from Corydalis saxicola. Planta Med. 2007;73:787\u2013791. doi: 10.1055/s-2007-981549.", "ArticleIdList": ["10.1055/s-2007-981549", "17611928"]}, {"Citation": "Kashiwada Y., Aoshima A., Ikeshiro Y., Chen Y.-P., Furukawa H., Itoigawa M., Fujioka T., Mihashi K., Cosentino L.M., Morris-Natschke S.L. Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure\u2013activity correlations with related alkaloids. Bioorganic Med. Chem. 2005;13:443\u2013448. doi: 10.1016/j.bmc.2004.10.020.", "ArticleIdList": ["10.1016/j.bmc.2004.10.020", "15598565"]}, {"Citation": "Tietjen I., Ntie-Kang F., Mwimanzi P., Ongu\u00e9n\u00e9 P.A., Scull M.A., Idowu T.O., Ogundaini A.O., Meva\u2019a L.M., Abegaz B.M., Rice C.M. Screening of the Pan-African natural product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors. PLoS ONE. 2015;10:e0121099. doi: 10.1371/journal.pone.0121099.", "ArticleIdList": ["10.1371/journal.pone.0121099", "PMC4382154", "25830320"]}, {"Citation": "Boustie J., Stigliani J.-L., Montanha J., Amoros M., Payard M., Girre L. Antipoliovirus structure\u2212 activity relationships of some aporphine alkaloids. J. Nat. Prod. 1998;61:480\u2013484. doi: 10.1021/np970382v.", "ArticleIdList": ["10.1021/np970382v", "9584402"]}, {"Citation": "Yu Z., Han C., Song X., Chen G., Chen J. Bioactive aporphine alkaloids from the stems of Dasymaschalon rostratum. Bioorganic Chem. 2019;90:103069. doi: 10.1016/j.bioorg.2019.103069.", "ArticleIdList": ["10.1016/j.bioorg.2019.103069", "31271945"]}, {"Citation": "Orhana I., Oz\u00e7elik B., Karao\u011flu T., Sener B. Antiviral and antimicrobial profiles of selected isoquinoline alkaloids from Fumaria and Corydalis species. Z. Nat. C J. Biosci. 2007;62:19\u201326. doi: 10.1515/znc-2007-1-204.", "ArticleIdList": ["10.1515/znc-2007-1-204", "17425100"]}, {"Citation": "Montanha J., Amoros M., Boustie J., Girre L. Anti-herpes virus activity of aporphine alkaloids. Planta Med. 1995;61:419\u2013424. doi: 10.1055/s-2006-958128.", "ArticleIdList": ["10.1055/s-2006-958128", "7480202"]}, {"Citation": "Ellinger B., Bojkova D., Zaliani A., Cinatl J., Claussen C., Westhaus S., Keminer O., Reinshagen J., Kuzikov M., Wolf M. A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection. Sci. Data. 2021;8:1\u201310. doi: 10.1038/s41597-021-00848-4.", "ArticleIdList": ["10.1038/s41597-021-00848-4", "PMC7910569", "33637768"]}, {"Citation": "Nokta M., Albrecht T., Pollard R. Papaverine hydrochloride: Effects on HIV replication and T-lymphocyte cell function. Immunopharmacology. 1993;26:181\u2013185. doi: 10.1016/0162-3109(93)90010-N.", "ArticleIdList": ["10.1016/0162-3109(93)90010-N", "7506701"]}, {"Citation": "Ma C.M., Nakamura N., Miyashiro H., Hattori M., Komatsu K., Kawahata T., Otake T. Screening of Chinese and Mongolian herbal drugs for anti-human immunodeficiency virus type 1 (HIV-1) activity. Phytother. Res. 2002;16:186\u2013189. doi: 10.1002/ptr.922.", "ArticleIdList": ["10.1002/ptr.922", "11933126"]}, {"Citation": "Otshudi A.L., Apers S., Pieters L., Claeys M., Pannecouque C., De Clercq E., Van Zeebroeck A., Lauwers S., Frederich M., Foriers A. Biologically active bisbenzylisoquinoline alkaloids from the root bark of Epinetrum villosum. J. Ethnopharmacol. 2005;102:89\u201394. doi: 10.1016/j.jep.2005.05.021.", "ArticleIdList": ["10.1016/j.jep.2005.05.021", "15996841"]}, {"Citation": "Wan Z., Lu Y., Liao Q., Wu Y., Chen X. Fangchinoline inhibits human immunodeficiency virus type 1 replication by interfering with gp160 proteolytic processing. PLoS ONE. 2012;7:e39225. doi: 10.1371/journal.pone.0039225.", "ArticleIdList": ["10.1371/journal.pone.0039225", "PMC3374765", "22720080"]}, {"Citation": "Kim D.E., Min J.S., Jang M.S., Lee J.Y., Shin Y.S., Song J.H., Kim H.R., Kim S., Jin Y.H., Kwon S. Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells. Biomolecules. 2019;9:696. doi: 10.3390/biom9110696.", "ArticleIdList": ["10.3390/biom9110696", "PMC6921063", "31690059"]}, {"Citation": "Hu M., Dutt J., Arrunategui-Correa V., Baltatzis S., Foster C.S. Cytokine mRNA in BALB/c mouse corneas infected with herpes simplex virus. Eye. 1999;13:309\u2013313. doi: 10.1038/eye.1999.80.", "ArticleIdList": ["10.1038/eye.1999.80", "10624423"]}, {"Citation": "He C.-L., Huang L.-Y., Wang K., Gu C.-J., Hu J., Zhang G.-J., Xu W., Xie Y.-H., Tang N., Huang A.-L. Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products. Signal Transduct. Target. Ther. 2021;6:131. doi: 10.1038/s41392-021-00531-5.", "ArticleIdList": ["10.1038/s41392-021-00531-5", "PMC7985570", "33758167"]}, {"Citation": "Heister P.M., Poston R.N. Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19. Pharmacol. Res. Perspect. 2020;8:e00653. doi: 10.1002/prp2.653.", "ArticleIdList": ["10.1002/prp2.653", "PMC7503088", "32930523"]}, {"Citation": "Glebov O.O. Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing. FEBS J. 2020;287:3664\u20133671. doi: 10.1111/febs.15369.", "ArticleIdList": ["10.1111/febs.15369", "PMC7276759", "32428379"]}, {"Citation": "Yang Y., Yang P., Huang C., Wu Y., Zhou Z., Wang X., Wang S. Inhibitory effect on SARS-CoV-2 infection of neferine by blocking Ca2+-dependent membrane fusion. J. Med. Virol. 2021;93:5825\u20135832. doi: 10.1002/jmv.27117.", "ArticleIdList": ["10.1002/jmv.27117", "34061377"]}, {"Citation": "Zhou H., Jiang H., Yao T., Zeng S. Fragmentation study on the phenolic alkaloid neferine and its analogues with anti-HIV activities by electrospray ionization tandem mass spectrometry with hydrogen/deuterium exchange and its application for rapid identification of in vitro microsomal metabolites of neferine. Rapid. Commun. Mass Spectrom. 2007;21:2120\u20132128.", "ArticleIdList": ["17546644"]}, {"Citation": "Huang L., Li H., Ye Z., Xu Q., Fu Q., Sun W., Qi W., Yue J. Berbamine inhibits Japanese encephalitis virus (JEV) infection by compromising TPRMLs-mediated endolysosomal trafficking of low-density lipoprotein receptor (LDLR) Emerg. Microbes Infect. 2021;10:1257\u20131271. doi: 10.1080/22221751.2021.1941276.", "ArticleIdList": ["10.1080/22221751.2021.1941276", "PMC8238074", "34102949"]}, {"Citation": "Huang L., Li H., Yuen T.T.-T., Ye Z., Fu Q., Sun W., Xu Q., Yang Y., Chan J.F.-W., Zhang G. Berbamine inhibits the infection of SARS-CoV-2 and flaviviruses by compromising TPRMLs-mediated endolysosomal trafficking of viral receptors. Signal Transduct. Target. Ther. 2020;6:1\u20133. doi: 10.1038/s41392-021-00584-6.", "ArticleIdList": ["10.1038/s41392-021-00584-6", "PMC8065329", "33895782"]}, {"Citation": "Xia B., Shen X., He Y., Pan X., Liu F.-L., Wang Y., Yang F., Fang S., Wu Y., Duan Z. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target. Cell Res. 2021;31:847\u2013860. doi: 10.1038/s41422-021-00519-4.", "ArticleIdList": ["10.1038/s41422-021-00519-4", "PMC8190750", "34112954"]}, {"Citation": "Nawawi A., Ma C., Nakamura N., Hattori M., Kurokawa M., Shiraki K., Kashiwaba N., Ono M. Anti-herpes simplex virus activity of alkaloids isolated from Stephania cepharantha. Biol Pharm Bull. 1999;22:268\u2013274. doi: 10.1248/bpb.22.268.", "ArticleIdList": ["10.1248/bpb.22.268", "10220283"]}, {"Citation": "Okamoto M., Ono M., Baba M. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells. AIDS Res. Hum. Retrovir. 1998;14:1239\u20131245. doi: 10.1089/aid.1998.14.1239.", "ArticleIdList": ["10.1089/aid.1998.14.1239", "9764907"]}, {"Citation": "Furusawa S., Wu J. The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: Implications for cancer, shock, and inflammatory diseases. Life Sci. 2007;80:1073\u20131079. doi: 10.1016/j.lfs.2006.12.001.", "ArticleIdList": ["10.1016/j.lfs.2006.12.001", "17204293"]}, {"Citation": "Matsuda K., Hattori S., Komizu Y., Kariya R., Ueoka R., Okada S. Cepharanthine inhibited HIV-1 cell\u2013cell transmission and cell-free infection via modification of cell membrane fluidity. Bioorganic Med. Chem. Lett. 2014;24:2115\u20132117. doi: 10.1016/j.bmcl.2014.03.041.", "ArticleIdList": ["10.1016/j.bmcl.2014.03.041", "24704028"]}, {"Citation": "Baba M., Okamoto M., Kashiwaba N., Ono M. Anti-HIV-1 activity and structure-activity relationship of cepharanoline derivatives in chronically infected cells. Antivir. Chem. Chemother. 2001;12:307\u2013312. doi: 10.1177/095632020101200506.", "ArticleIdList": ["10.1177/095632020101200506", "11900350"]}, {"Citation": "Liu X., Wang Y., Zhang M., Li G., Cen Y. Study on the inhibitory effect of cepharanthine on herpes simplex type-1 virus (HSV-1) in vitro. J. Chin. Med. Mater. 2004;27:107\u2013110.", "ArticleIdList": ["22454997"]}, {"Citation": "Okamoto M., Ono M., Baba M. Suppression of cytokine production and neural cell death by the anti-inflammatory alkaloid cepharanthine: A potential agent against HIV-1 encephalopathy. Biochem. Pharm. 2001;62:747\u2013753. doi: 10.1016/S0006-2952(01)00692-X.", "ArticleIdList": ["10.1016/S0006-2952(01)00692-X", "11551520"]}, {"Citation": "Zhang C.H., Wang Y.F., Liu X.J., Lu J.H., Qian C.W., Wan Z.Y., Yan X.G., Zheng H.Y., Zhang M.Y., Xiong S., et al. Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro. Chin. Med. J. (Engl.) 2005;118:493\u2013496.", "ArticleIdList": ["15788131"]}, {"Citation": "Ohashi H., Watashi K., Saso W., Shionoya K., Iwanami S., Hirokawa T., Shirai T., Kanaya S., Ito Y., Kim K.S. Multidrug treatment with nelfinavir and cepharanthine against COVID-19. BioRxiv. 2020 doi: 10.1101/2020.04.14.039925.", "ArticleIdList": ["10.1101/2020.04.14.039925", "PMC7997640", "33817567"]}, {"Citation": "Nawawi A., Nakamura N., Hattori M., Kurokawa M., Shiraki K. Inhibitory effects of Indonesian medicinal plants on the infection of herpes simplex virus type 1. Phytother. Res. 1999;13:37\u201341. doi: 10.1002/(SICI)1099-1573(199902)13:1<37::AID-PTR382>3.0.CO;2-S.", "ArticleIdList": ["10.1002/(SICI)1099-1573(199902)13:1<37::AID-PTR382>3.0.CO;2-S", "10189948"]}, {"Citation": "Dyall J., Coleman C.M., Venkataraman T., Holbrook M.R., Kindrachuk J., Johnson R.F., Olinger Jr G.G., Jahrling P.B., Laidlaw M., Johansen L.M. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob. Agents Chemother. 2014;58:4885\u20134893. doi: 10.1128/AAC.03036-14.", "ArticleIdList": ["10.1128/AAC.03036-14", "PMC4136000", "24841273"]}, {"Citation": "Boyd M.R., Hallock Y.F., Cardellina J.H., 2nd, Manfredi K.P., Blunt J.W., Mcmahon J.B., Buckheit R.W., Jr., Bringmann G., Schaffer M., Cragg G.M., et al. Anti-HIV michellamines from Ancistrocladus korupensis. J. Med. Chem. 1994;37:1740\u20131745. doi: 10.1021/jm00038a003.", "ArticleIdList": ["10.1021/jm00038a003", "8021914"]}, {"Citation": "McMahon J.B., Currens M.J., Gulakowski R.J., Buckheit R.W., Jr., Lackman-Smith C., Hallock Y.F., Boyd M.R. Michellamine B a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms. Antimicrob. Agents Chemother. 1995;39:484\u2013488. doi: 10.1128/AAC.39.2.484.", "ArticleIdList": ["10.1128/AAC.39.2.484", "PMC162564", "7537029"]}, {"Citation": "Bringmann G., Steinert C., Feineis D., Mudogo V., Betzin J., Scheller C. HIV-inhibitory michellamine-type dimeric naphthylisoquinoline alkaloids from the Central African liana Ancistrocladus congolensis. Phytochemistry. 2016;128:71\u201381. doi: 10.1016/j.phytochem.2016.04.005.", "ArticleIdList": ["10.1016/j.phytochem.2016.04.005", "27137461"]}, {"Citation": "Angelova A., Tenev T., Varadinova T. Expression of cellular proteins Bcl-X (L), XIAP and Bax involved in apoptosis in cells infected with herpes simplex virus 1 and effect of pavine alkaloid (-)-thalimonine on virus-induced suppression of apoptosis. Acta Virol. 2004;48:193\u2013196.", "ArticleIdList": ["15595215"]}, {"Citation": "Vanquelef E., Amoros M., Boustie J., Lynch M.A., Waigh R.D., Duval O. Synthesis and antiviral effect against herpes simplex type 1 of 12-substituted benzo [c] phenanthridinium salts. J. Enzym. Inhib. Med. Chem. 2004;19:481\u2013487. doi: 10.1080/14756360412331280518.", "ArticleIdList": ["10.1080/14756360412331280518", "15662952"]}, {"Citation": "Tan G.T., Miller J.F., Kinghorn A.D., Hughes S.H., Pezzuto J.M. HIV-1 and HIV-2 reverse transcriptases: A comparative study of sensitivity to inhibition by selected natural products. Biochem. Biophys. Res. Commun. 1992;185:370\u2013378. doi: 10.1016/S0006-291X(05)80995-7.", "ArticleIdList": ["10.1016/S0006-291X(05)80995-7", "1376118"]}, {"Citation": "Cheng T.-J., Goodsell D.S., Kan C.-C. Identification of sanguinarine as a novel HIV protease inhibitor from high-throughput screening of 2,000 drugs and natural products with a cell-based assay. Lett. Drug Des. Discov. 2005;2:364\u2013371. doi: 10.2174/1570180054405811.", "ArticleIdList": ["10.2174/1570180054405811"]}, {"Citation": "Shen L., Niu J., Wang C., Huang B., Wang W., Zhu N., Deng Y., Wang H., Ye F., Cen S. High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses. J. Virol. 2019;93:e00023-19. doi: 10.1128/JVI.00023-19.", "ArticleIdList": ["10.1128/JVI.00023-19", "PMC6613765", "30918074"]}, {"Citation": "Leitao Da-Cunha E.V., Fechine I.M., Guedes D.N., Barbosa-Filho J.M., Sobral Da Silva M. In: Protoberberine Alkaloids. Cordell G.A., editor. Vol. 62. Academic Press; Cambridge, MA, USA: 2005. pp. 1\u201375. The Alkaloids: Chemistry and Biology.", "ArticleIdList": ["16265921"]}, {"Citation": "Babalghith A.O., Al-Kuraishy H.M., Al-Gareeb A.I., De Waard M., Al-Hamash S.M., Jean-Marc S., Negm W.A., Batiha G.E.-S. The role of berberine in Covid-19: Potential adjunct therapy. Inflammopharmacology. 2022;3(6):2003\u20132016. doi: 10.1007/s10787-022-01080-1.", "ArticleIdList": ["10.1007/s10787-022-01080-1", "PMC9526677", "36183284"]}, {"Citation": "Liu H., You L., Wu J., Zhao M., Guo R., Zhang H., Su R., Mao Q., Deng D., Hao Y. Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS. J. Leukoc. Biol. 2020;108:253\u2013266. doi: 10.1002/JLB.3MA0320-358RR.", "ArticleIdList": ["10.1002/JLB.3MA0320-358RR", "32272506"]}, {"Citation": "Wu Y., Li J.-Q., Kim Y.-J., Wu J., Wang Q., Hao Y. In vivo and in vitro antiviral effects of berberine on influenza virus. Chin. J. Integr. Med. 2011;17:444\u2013452. doi: 10.1007/s11655-011-0640-3.", "ArticleIdList": ["10.1007/s11655-011-0640-3", "21660679"]}, {"Citation": "Li H.L., Han T., Liu R.H., Zhang C., Chen H.S., Zhang W.D. Alkaloids from Corydalis saxicola and their anti-hepatitis B virus activity. Chem. Biodivers. 2008;5:777\u2013783. doi: 10.1002/cbdv.200890074.", "ArticleIdList": ["10.1002/cbdv.200890074", "18493964"]}, {"Citation": "Aljofan M., Netter H.J., Aljarbou A.N., Hadda T.B., Orhan I.E., Sener B., Mungall B.A. Anti-hepatitis B activity of isoquinoline alkaloids of plant origin. Arch. Virol. 2014;159:1119\u20131128. doi: 10.1007/s00705-013-1937-7.", "ArticleIdList": ["10.1007/s00705-013-1937-7", "24311152"]}, {"Citation": "Ng T.B., Huang B., Fong W.P., Yeung H.W. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors. Life Sci. 1997;61:933\u2013949. doi: 10.1016/S0024-3205(97)00245-2.", "ArticleIdList": ["10.1016/S0024-3205(97)00245-2", "9296332"]}, {"Citation": "Yao M., Fan X., Yuan B., Takagi N., Liu S., Han X., Ren J., Liu J. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell. BMC Complement. Altern. Med. 2019;19:1\u201311. doi: 10.1186/s12906-019-2615-4.", "ArticleIdList": ["10.1186/s12906-019-2615-4", "PMC6694465", "31412862"]}, {"Citation": "Yang L.M., Wang R., Li J.J., Li N.S., Zheng Y.T. Anti-HIV-1 activities of four berberine compounds in vitro. Chin. J. Nat. Med. 2007;5:225\u2013228."}, {"Citation": "Kaur R., Sharma P., Gupta G.K., Ntie-Kang F., Kumar D. Structure-Activity-Relationship and Mechanistic Insights for Anti-HIV Natural Products. Molecules. 2020;25:2070. doi: 10.3390/molecules25092070.", "ArticleIdList": ["10.3390/molecules25092070", "PMC7249135", "32365518"]}, {"Citation": "Ge Y.-C., Wang K.-W. New analogues of aporphine alkaloids. Mini Rev. Med. Chem. 2018;18:1590\u20131602. doi: 10.2174/1389557518666180423151426.", "ArticleIdList": ["10.2174/1389557518666180423151426", "29692245"]}, {"Citation": "Reddy M.V., Rao M.R., Rhodes D., Hansen M.S., Rubins K., Bushman F.D., Venkateswarlu Y., Faulkner D.J. Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture. J. Med. Chem. 1999;42:1901\u20131907. doi: 10.1021/jm9806650.", "ArticleIdList": ["10.1021/jm9806650", "10354398"]}, {"Citation": "Fukuda T., Ishibashi F., Iwao M. Lamellarin Alkaloids: Isolation, Synthesis, and Biological Activity. Alkaloids Chem. Biol. 2020;83:1\u2013112.", "ArticleIdList": ["32098648"]}, {"Citation": "Mediouni S., Chinthalapudi K., Ekka M.K., Usui I., Jablonski J.A., Clementz M.A., Mousseau G., Nowak J., Macherla V.R., Beverage J.N. Didehydro-cortistatin A inhibits HIV-1 by specifically binding to the unstructured basic region of Tat. mBio. 2019;10:e02662-18. doi: 10.1128/mBio.02662-18.", "ArticleIdList": ["10.1128/mBio.02662-18", "PMC6368365", "30723126"]}, {"Citation": "Kessing C.F., Nixon C.C., Li C., Tsai P., Takata H., Mousseau G., Ho P.T., Honeycutt J.B., Fallahi M., Trautmann L., et al. In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a \"Block-and-Lock\" Strategy for HIV-1 Treatment. Cell Rep. 2017;21:600\u2013611. doi: 10.1016/j.celrep.2017.09.080.", "ArticleIdList": ["10.1016/j.celrep.2017.09.080", "PMC5653276", "29045830"]}, {"Citation": "Mohamed S.M., Hassan E.M., Ibrahim N.A. Cytotoxic and antiviral activities of aporphine alkaloids of Magnolia grandiflora L. Nat. Prod. Res. 2010;24:1395\u20131402. doi: 10.1080/14786410902906959.", "ArticleIdList": ["10.1080/14786410902906959", "19764006"]}, {"Citation": "Avci F.G., Atas B., Gulsoy Toplan G., Gurer C., Sariyar Akbulut B. In: Chapter 4\u2014Antibacterial and Antifungal Activities of Isoquinoline Alkaloids of the Papaveraceae and Fumariaceae Families and Their Implications in Structure\u2013Activity Relationships. Atta ur R., editor. Vol. 70. Elsevier; Amsterdam, The Netherlands: 2021. pp. 87\u2013118. Studies in Natural Products Chemistry."}, {"Citation": "Kim H.-Y., Shin H.-S., Park H., Kim Y.-C., Yun Y.G., Park S., Shin H.-J., Kim K. In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex. J. Clin. Virol. 2008;41:122\u2013128. doi: 10.1016/j.jcv.2007.10.011.", "ArticleIdList": ["10.1016/j.jcv.2007.10.011", "PMC7108295", "18036887"]}, {"Citation": "Khan T., Khan M.A., Ullah N., Nadhman A. Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites. Biocatal. Agric. Biotechnol. 2021;31:101890. doi: 10.1016/j.bcab.2020.101890.", "ArticleIdList": ["10.1016/j.bcab.2020.101890", "PMC7831775", "33520034"]}, {"Citation": "Pham L.V., Ngo H.T., Lim Y.-S., Hwang S.B. Hepatitis C virus non-structural 5B protein interacts with cyclin A2 and regulates viral propagation. J. Hepatol. 2012;57:960\u2013966. doi: 10.1016/j.jhep.2012.07.006.", "ArticleIdList": ["10.1016/j.jhep.2012.07.006", "22796893"]}, {"Citation": "Li S.-Y., Chen C., Zhang H.-Q., Guo H.-Y., Wang H., Wang L., Zhang X., Hua S.-N., Yu J., Xiao P.-G. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir. Res. 2005;67:18\u201323. doi: 10.1016/j.antiviral.2005.02.007.", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Cao J., Forrest J.C., Zhang X. A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs. Antivir. Res. 2015;114:1\u201310. doi: 10.1016/j.antiviral.2014.11.010.", "ArticleIdList": ["10.1016/j.antiviral.2014.11.010", "PMC7113785", "25451075"]}, {"Citation": "Yang C.-W., Lee Y.-Z., Kang I.-J., Barnard D.L., Jan J.-T., Lin D., Huang C.-W., Yeh T.-K., Chao Y.-S., Lee S.-J. Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus. Antivir. Res. 2010;88:160\u2013168. doi: 10.1016/j.antiviral.2010.08.009.", "ArticleIdList": ["10.1016/j.antiviral.2010.08.009", "PMC7114283", "20727913"]}, {"Citation": "Jahan I., Ahmet O. Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turk. J. Biol. 2020;44:228\u2013241. doi: 10.3906/biy-2005-114.", "ArticleIdList": ["10.3906/biy-2005-114", "PMC7314514", "32595359"]}, {"Citation": "George A., Gopi Krishna Reddy A., Satyanarayana G., Raghavendra N.K. 1,2,3,4-Tetrahydroisoquinolines as inhibitors of HIV-1 integrase and human LEDGF/p75 interaction. Chem. Biol. Drug Des. 2018;91:1133\u20131140. doi: 10.1111/cbdd.13175.", "ArticleIdList": ["10.1111/cbdd.13175", "29405651"]}, {"Citation": "Turano A.S.G., Caruso a Bonfanti C., Luzzati R., Bassetti D., Manca N. Inhibitory effect of papaverine on HIV replication in vitro. AIDS Res. Hum. Retrovir. 1989;5:183\u2013192. doi: 10.1089/aid.1989.5.183.", "ArticleIdList": ["10.1089/aid.1989.5.183", "2713167"]}, {"Citation": "Nishiyama Y., Iwasa K., Okada S., Takeuchi S., Moriyasu M., Kamigauchi M., Koyama J., Takeuchi A., Tokuda H., Kim H.S. Geranyl derivatives of isoquinoline alkaloids show increased biological activities. Heterocycles. 2010;81:1193\u20131229. doi: 10.3987/COM-10-11912.", "ArticleIdList": ["10.3987/COM-10-11912"]}, {"Citation": "Iwasa K., Moriyasu M., Tachibana Y., Kim H.-S., Wataya Y., Wiegrebe W., Bastow K.F., Cosentino L.M., Kozuka M., Lee K.-H. Simple Isoquinoline and Benzylisoquinoline Alkaloids as Potential Antimicrobial, Antimalarial, Cytotoxic, and Anti-HIV Agents. Bioorganic Med. Chem. 2001;9:2871\u20132884. doi: 10.1016/S0968-0896(01)00154-7.", "ArticleIdList": ["10.1016/S0968-0896(01)00154-7", "11597468"]}, {"Citation": "Weber C., Opatz T. In: Chapter One\u2014Bisbenzylisoquinoline Alkaloids, The Alkaloids: Chemistry and Biology. Kn\u00f6lker H.-J., editor. Academic Press; Cambridge, MA, USA: 2019. pp. 1\u2013114.", "ArticleIdList": ["30685048"]}, {"Citation": "Okamoto M., Okamoto T., Baba M. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells. Antimicrob. Agents Chemother. 1999;43:492\u2013497. doi: 10.1128/AAC.43.3.492.", "ArticleIdList": ["10.1128/AAC.43.3.492", "PMC89149", "10049256"]}, {"Citation": "Liu Y., Tang Q., Rao Z., Fang Y., Jiang X., Liu W., Luan F., Zeng N. Inhibition of herpes simplex virus 1 by cepharanthine via promoting mcellular autophagy through up-regulation of STING/TBK1/P62 pathway. Antivir. Res. 2021;193:105143. doi: 10.1016/j.antiviral.2021.105143.", "ArticleIdList": ["10.1016/j.antiviral.2021.105143", "34303748"]}, {"Citation": "Fan H.-H., Wang L.-Q., Liu W.-L., An X.-P., Liu Z.-D., He X.-Q., Song L.-H., Tong Y.-G. Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model. Chin. Med. J. 2020;133:1051\u20131056. doi: 10.1097/CM9.0000000000000797.", "ArticleIdList": ["10.1097/CM9.0000000000000797", "PMC7147283", "32149769"]}, {"Citation": "Li S., Liu W., Chen Y., Wang L., An W., An X., Song L., Tong Y., Fan H., Lu C. Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus. Brief. Bioinform. 2021;22:1378\u20131386. doi: 10.1093/bib/bbaa387.", "ArticleIdList": ["10.1093/bib/bbaa387", "PMC7929461", "33423067"]}, {"Citation": "Dong S., Yu R., Wang X., Chen B., Si F., Zhou J., Xie C., Li Z., Zhang D. Bis-Benzylisoquinoline Alkaloids Inhibit Porcine Epidemic Diarrhea Virus In Vitro and In Vivo. Viruses. 2022;14:1231. doi: 10.3390/v14061231.", "ArticleIdList": ["10.3390/v14061231", "PMC9228057", "35746702"]}, {"Citation": "Li H., Chen X., Zhou S.-J. Dauricine combined with clindamycin inhibits severe pneumonia co-infected by influenza virus H5N1 and Streptococcus pneumoniae in vitro and in vivo through NF-\u03baB signaling pathway. J. Pharmacol. Sci. 2018;137:12\u201319. doi: 10.1016/j.jphs.2018.01.011.", "ArticleIdList": ["10.1016/j.jphs.2018.01.011", "29769163"]}, {"Citation": "Zeng X., Lao B., Dong X., Sun X., Dong Y., Sheng G., Fu J. Study on anti-influenza effect of alkaloids from roots of Mahonia bealei in vitro. Zhong Yao Cai. 2003;26:29\u201330.", "ArticleIdList": ["12858771"]}, {"Citation": "Hu S., Dutt J., Zhao T., Foster C.S. Stephen Foster Tetrandrine potently inhibits herpes simplex virus type-1-induced keratitis in BALB/c mice. Ocul. Immunol. Inflamm. 1997;5 doi: 10.3109/09273949709116892.", "ArticleIdList": ["10.3109/09273949709116892", "9326762"]}, {"Citation": "Wink M. Potential of DNA intercalating alkaloids and other plant secondary metabolites against SARS-CoV-2 causing COVID-19. Diversity. 2020;12:175. doi: 10.3390/d12050175.", "ArticleIdList": ["10.3390/d12050175"]}, {"Citation": "Yang S., Xu M., Lee E.M., Gorshkov K., Shiryaev S.A., He S., Sun W., Cheng Y., Hu X., Tharappel A.M., et al. Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: Inhibiting viral replication and decreasing viral entry. Cell Discov. 2018;4:31. doi: 10.1038/s41421-018-0034-1.", "ArticleIdList": ["10.1038/s41421-018-0034-1", "PMC5986771", "29872540"]}, {"Citation": "Andersen P.I., Krpina K., Ianevski A., Shtaida N., Jo E., Yang J., Koit S., Tenson T., Hukkanen V., Anthonsen M.W., et al. Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine. Viruses. 2019;11:964. doi: 10.3390/v11100964.", "ArticleIdList": ["10.3390/v11100964", "PMC6832696", "31635418"]}, {"Citation": "Tan G.T., Kinghorn A.D., Hughes S.H., Pezzuto J.M. Psychotrine and its O-methyl ether are selective inhibitors of human immunodeficiency virus-1 reverse transcriptase. J. Biol.Chem. 1991;266:23529\u201323536. doi: 10.1016/S0021-9258(18)54314-3.", "ArticleIdList": ["10.1016/S0021-9258(18)54314-3", "1721050"]}, {"Citation": "Tan G.T., Pezzuto J.M., Kinghorn A.D., Hughes S.H. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J. Nat. Prod. 1991;54:143\u2013154. doi: 10.1021/np50073a012.", "ArticleIdList": ["10.1021/np50073a012", "1710653"]}, {"Citation": "Manfredi K.P., Blunt J.W., Cardellina J.H., 2nd, Mcmahon J.B., Pannell L.L., Cragg G.M., Boyd M.R. Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2. J. Med. Chem. 1991;34:3402\u20133405. doi: 10.1021/jm00116a011.", "ArticleIdList": ["10.1021/jm00116a011", "1766007"]}, {"Citation": "White E.L., Chao W.R., Ross L.J., Borhani D.W., Hobbs P.D., Upender V., Dawson M.I. Michellamine alkaloids inhibit protein kinase C. Arch. Biochem. Biophys. 1999;365:25\u201330. doi: 10.1006/abbi.1999.1145.", "ArticleIdList": ["10.1006/abbi.1999.1145", "10222035"]}, {"Citation": "Supko Jg M.L. Pharmacokinetics of michellamine B, a naphthylisoquinoline alkaloid with in vitro activity against human immunodeficiency virus types 1 and 2, in the mouse and dog. Antimicrob. Agents Chemother. 1995;39:9\u201314. doi: 10.1128/AAC.39.1.9.", "ArticleIdList": ["10.1128/AAC.39.1.9", "PMC162476", "7695336"]}, {"Citation": "Hallock Y.F., Manfredi K.P., Dai J.-R., Cardellina J.H., Gulakowski R.J., Mcmahon J.B., Sch\u00e4ffer M., Stahl M., Gulden K.-P., Bringmann G. Michellamines D\u2212 F, new HIV-inhibitory dimeric naphthylisoquinoline alkaloids, and korupensamine E, a new antimalarial monomer, from Ancistrocladus korupensis. J. Nat. Prod. 1997;60:677\u2013683. doi: 10.1021/np9700679.", "ArticleIdList": ["10.1021/np9700679", "9249970"]}, {"Citation": "Ka S., Merindol N., Sow A.A., Singh A., Landelouci K., Plourde M.B., P\u00e9pin G., Masi M., Di Lecce R., Evidente A. Amaryllidaceae alkaloid cherylline inhibits the replication of dengue and Zika viruses. Antimicrob. Agents Chemother. 2021;65:e00398-21. doi: 10.1128/AAC.00398-21.", "ArticleIdList": ["10.1128/AAC.00398-21", "PMC8370201", "34152811"]}, {"Citation": "Homan J.W., Steele A.D., Martinand-Mari C., Rogers T.J., Henderson E.E., Charubala R., Pfleiderer W., Reichenbach N.L., Suhadolnik R.J. Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B) JAIDS J. Acquir. Immune Defic. Syndr. 2002;30:9\u201320. doi: 10.1097/00042560-200205010-00002.", "ArticleIdList": ["10.1097/00042560-200205010-00002", "12048358"]}, {"Citation": "Sun W.W. Postgraduate Thesis. Northwest A&F University; ShanXi, China: Structural Modification, Bioactivity of Derivatives of Three Protopines and Their Structure-Activity Relationship."}, {"Citation": "Huang Q., Wu X., Zheng X., Luo S., Xu S., Weng J. Targeting inflammation and cytokine storm in COVID-19. Pharmacol. Res. 2020;159:105051. doi: 10.1016/j.phrs.2020.105051.", "ArticleIdList": ["10.1016/j.phrs.2020.105051", "PMC7320704", "32603772"]}, {"Citation": "Choi H.S., Kim H.S., Min K.R., Kim Y., Lim H.K., Chang Y.K., Chung M.W. Anti-inflammatory effects of fangchinoline and tetrandrine. J. Ethnopharmacol. 2000;69:173\u2013179. doi: 10.1016/S0378-8741(99)00141-5.", "ArticleIdList": ["10.1016/S0378-8741(99)00141-5", "10687873"]}, {"Citation": "Wu S.-J., Ng L.-T. Tetrandrine Inhibits Proinflammatory Cytokines, iNOS and COX-2 Expression in Human Monocytic Cells. Biol. Pharm. Bull. 2007;30:59\u201362. doi: 10.1248/bpb.30.59.", "ArticleIdList": ["10.1248/bpb.30.59", "17202660"]}, {"Citation": "Xue Y., Wang Y., Feng D.-C., Xiao B.-G., Xu L.-Y. Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-\u03baB pathway. Acta Pharmacol. Sin. 2008;29:245\u2013251. doi: 10.1111/j.1745-7254.2008.00734.x.", "ArticleIdList": ["10.1111/j.1745-7254.2008.00734.x", "18215355"]}, {"Citation": "Eissa L.A., Kenawy H.I., El-Karef A., Elsherbiny N.M., El-Mihi K.A. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Chem. -Biol. Interact. 2018;294:91\u2013100. doi: 10.1016/j.cbi.2018.08.016.", "ArticleIdList": ["10.1016/j.cbi.2018.08.016", "30138605"]}, {"Citation": "Ebrahimi S.A. Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2. Drug Dev. Res. 2020;81:765\u2013767. doi: 10.1002/ddr.21676.", "ArticleIdList": ["10.1002/ddr.21676", "PMC7267448", "32337769"]}, {"Citation": "Xia H., Liu Y., Xia G., Liu Y., Lin S., Guo L. Novel isoquinoline alkaloid litcubanine A-a potential anti-inflammatory candidate. Front. Immunol. 2021:1987. doi: 10.3389/fimmu.2021.685556.", "ArticleIdList": ["10.3389/fimmu.2021.685556", "PMC8215673", "34163484"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "14"}, {"Year": "2022", "Month": "12", "Day": "10"}, {"Year": "2022", "Month": "12", "Day": "15"}, {"Year": "2023", "Month": "1", "Day": "21", "Hour": "1", "Minute": "6"}, {"Year": "2023", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["36671402", "PMC9856122", "10.3390/biom13010017", "biom13010017"]}}], "PubmedBookArticle": []}